American Cancer Society – Diversity in clinical trials helps ensure that new treatments are effective for everyone

American Cancer Society shared on LinkedIn:

“Clinical trials play an important role developing new treatments for serious diseases, especially cancer. Diversity in these trials helps ensure that new treatments are effective for everyone. That’s why our partnership with Trial Library, Inc., and Prostate Cancer Clinical Trials Consortium (PCCTC) will support community practices to advance access to prostate cancer clinical trials for Black patients.

This collaboration aligns well with our existing work to spread the word to the Black communities about the importance of early detection for prostate cancer with Pfizer’s ChangetheOdds: Uniting to Improve Cancer Outcomes™.”

Read further.
Source: American Cancer Society/LinkedIn